Published in:
Open Access
01-12-2019 | Whooping Cough | Commentary
Comment on the trial protocol “Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial”
Authors:
Sanne Marie Thysen, Ane Bærent Fisker
Published in:
Trials
|
Issue 1/2019
Login to get access
Excerpt
We have read with interest the study protocol by Nankabirwa et al. [
1]. The authors propose a study of the non-specific effects (NSEs) of Bacillus Calmette-Guérin (BCG) vaccine in HIV-1-exposed children. Children will be randomised to BCG at birth or at 14 weeks of age. Follow-up for the main outcome is planned from 0 to 14 weeks. …